These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19394800)

  • 1. Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
    Giannarini G; Autorino R
    Int J Antimicrob Agents; 2009 Sep; 34(3):283-4. PubMed ID: 19394800
    [No Abstract]   [Full Text] [Related]  

  • 2. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
    Cai T; Mazzoli S; Bechi A; Addonisio P; Mondaini N; Pagliai RC; Bartoletti R
    Int J Antimicrob Agents; 2009 Jun; 33(6):549-53. PubMed ID: 19181486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
    Busetto GM; Giovannone R; Ferro M; Tricarico S; Del Giudice F; Matei DV; De Cobelli O; Gentile V; De Berardinis E
    BMC Urol; 2014 Jul; 14():53. PubMed ID: 25038794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens.
    Marzano R; Dinelli N; Ales V; Bertozzi MA
    Arch Ital Urol Androl; 2015 Mar; 87(1):25-7. PubMed ID: 25847892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.
    Cai T; Mazzoli S; Addonisio P; Boddi V; Geppetti P; Bartoletti R
    Methods Find Exp Clin Pharmacol; 2010; 32(1):39-45. PubMed ID: 20383345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
    Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
    J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Associating Serenoa repens, Urtica dioica and Pinus pinaster. Safety and efficacy in the treatment of lower urinary tract symptoms. Prospective study on 320 patients].
    Pavone C; Abbadessa D; Tarantino ML; Oxenius I; Laganà A; Lupo A; Rinella M
    Urologia; 2010; 77(1):43-51. PubMed ID: 20890858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study.
    Stamatiou K; Pierris N
    Arch Ital Urol Androl; 2013 Dec; 85(4):190-6. PubMed ID: 24399120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
    Rafailidis PI; Polyzos KA; Sgouros K; Falagas ME
    Int J Antimicrob Agents; 2011 Apr; 37(4):283-90. PubMed ID: 21300527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prulifloxacin as a trigger of myasthenia gravis.
    Rossi M; Lusini G; Biasella A; Mazzocchio R
    J Neurol Sci; 2009 May; 280(1-2):109-10. PubMed ID: 19232642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gentos in the treatment of chronic abacterial prostatitis].
    Loran OB; Pushkar' DIu; Tedeev VV; Nosovitskiĭ PB
    Urologiia; 2003; (6):30-2. PubMed ID: 14708242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2007; (2):80-2. PubMed ID: 17578203
    [No Abstract]   [Full Text] [Related]  

  • 15. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
    Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
    Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of PRO 160/120 (a combination of sabal and urtica extract) in patients with lower urinary tract symptoms (LUTS).
    Bondarenko B; Walther C; Funk P; Schläfke S; Engelmann U
    Phytomedicine; 2003; 10 Suppl 4():53-5. PubMed ID: 12807343
    [No Abstract]   [Full Text] [Related]  

  • 17. Phytotherapy in chronic prostatitis.
    Shoskes DA
    Urology; 2002 Dec; 60(6 Suppl):35-7; discussion 37. PubMed ID: 12521591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
    Pasqua F; Biscione G; Crigna G; Cazzola M
    Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of orally administered prulifloxacin into human prostate tissue.
    Giberti C; Gallo F; Rosignoli MT; Ruggieri A; Barattè S; Picollo R; Dionisio P
    Clin Drug Investig; 2009; 29(1):27-34. PubMed ID: 19067472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells.
    Scaglione F; Lucini V; Pannacci M; Caronno A; Leone C
    Pharmacology; 2008; 82(4):270-5. PubMed ID: 18849646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.